Ocular Symptoms in ANCA-Associated Vasculitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses optical coherence tomography angiography to characterize eye involvement in ANCA-associated vasculitis. It includes adults with GPA, MPA, or related conditions, whether or not they are currently treated. The goal is to describe ocular manifestations and their relationship to systemic disease activity. Data will be collected from participants at the Military Institute of Medicine in Warsaw. The study does not involve experimental treatment and aims to improve understanding of eye-related complications in this patient group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

ANCA positive vasculitis age 18- no limit patients with onset od the disease and patients already under treatment

\-

Exclusion Criteria:

* no consent for ophthalmic examination
* inability to udergo ophthalmic examination

Where it's running

• Military Institute of Medicine National Research Institute
  Warsaw, Poland Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for women with vasculitis during pregnancy

  This study is gathering information from pregnant women with vasculitis to understand their experiences and health outcomes during and after pregnancy.

  Recruiting University of Pennsylvania · Tampa, Florida · NCT02593565

• Evaluating skin lesions in patients with various types of vasculitis

  This study is testing how skin lesions from different types of vasculitis look under a microscope to help doctors better understand and treat these conditions.

  Recruiting at 4 sites University of Pennsylvania · Los Angeles, California and 9 other locations · NCT03004326

• Systemic Vasculitis Prognosis and Outcome

  This study follows patients suspected or diagnosed with systemic vasculitis over 10 years to see how their disease progresses and what factors predict outcomes.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Pavia · NCT07586137

• Reducing unnecessary medications in older adults with rheumatic conditions

  This project will test whether giving doctors individualized MedSafer reports plus patient EMPOWER brochures helps people 60+ with rheumatic conditions who take five or more regular medications stop or reduce risky medicines.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07278609

• TAVNEOS for ENT symptoms in GPA

  This study tests whether adding avacopan to standard care can help people with granulomatosis with polyangiitis who have active ear, nose, and throat symptoms.

  Recruiting at 2 sites Phase 2/3 Hospital for Special Surgery, New York · Edison, New Jersey and 1 other locations · NCT07176546

• Low-dose steroid treatment with standard induction medicines for ANCA-associated vasculitis affecting the kidneys

  This trial will test whether giving only 4 weeks of steroids together with usual induction medicines (cyclophosphamide or rituximab) helps people with ANCA-associated vasculitis that has severely affected the kidneys while reducing steroid-related harms.

  Recruiting Phase 3 Ottawa Hospital Research Institute · Hamilton, Ontario and 1 other locations · NCT06983821

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.